Forty plaintiffs recently filed a lawsuit against agribusiness giant Monsanto in California, alleging that exposure to the herbicide Roundup was the cause of their illness – specifically, non-Hodgkin lymphoma, a form of blood cancer that attacks the lymphatic system. Furthermore, plaintiffs allege that Monsanto has been falsifying data and attempting to discredit legitimate research into the health effects of Roundup's active ingredient, glyphosate.
Once again, a federal regulatory agency charged with the task of protecting consumers and the public has caved in to the demands of industry lobbyists. Just before the Environmental Protection Agency was scheduled to hold meetings of its Scientific Advisory Panel to discuss the carcinogenicity of glyphosate (the active ingredient in the controversial herbicide Roundup), CropLife America (CLA) raised objections over the presence of two scientists at the meeting.
Less than two weeks ago, The Ring of Fire reported that the FDA would finally be testing a wide range of food products for the presence of glyphosate, the active ingredient in the Monsanto herbicide Roundup. It didn't take long to find glysophate residues in a number of different baby foods. Specifically, elevated levels (up to 1.67 parts per million) of glysophate have been discovered in commercial oat meal products intended for infants.
Monsanto Gets Continued Government Approval for its Carcinogen Roundup Using Studies Paid for by Monsanto
Last year, the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), determined that glyphosate, the active ingredient in Monsanto's herbicide Roundup®, is a likely carcinogen. This finding has been reinforced by numerous scientific studies demonstrating that glyphosate has a detrimental effect on the human endocrine system (which produces and regulates hormones). This, in turn, can lead to the development of certain types of cancer, particularly of the lymph nodes.